---
title: "TYZ: The National Industrial Investment Fund plans to inquire about the transfer of 3.01% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244418863.md"
description: "According to the Zhitong Finance APP, TYZ disclosed the shareholder inquiry transfer plan, with the participating shareholder being the National Industrial Investment Fund; the total number of shares to be transferred is 6.76 million shares, accounting for 3.01% of the company's total share capital"
datetime: "2025-06-13T10:17:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244418863.md)
  - [en](https://longbridge.com/en/news/244418863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244418863.md)
generator: "portal-rs"
---

# TYZ: The National Industrial Investment Fund plans to inquire about the transfer of 3.01% of the company's shares

According to the Zhitong Finance APP, TYZ (688722.SH) disclosed the shareholder inquiry transfer plan, with the participating shareholder being the National Industrial Investment Fund; the total number of shares to be transferred is 6.76 million shares, accounting for 3.01% of the company's total share capital

### Related Stocks

- [688722.CN](https://longbridge.com/en/quote/688722.CN.md)

## Related News & Research

- [EXPLAINER-US Treasury yields are rising — Why does it matter?](https://longbridge.com/en/news/297670038.md)
- [There's A Lot To Like About APL Apollo Tubes' (NSE:APLAPOLLO) Upcoming ₹8.50 Dividend](https://longbridge.com/en/news/297970363.md)
- [REG - Harwood Capital Mgmt Odyssean Inv. Trust Gooch & Housego PLC - Form 8.3 - Gooch & Housego plc](https://longbridge.com/en/news/297792293.md)
- [12:09 ETHaier Biomedical präsentiert automatisierte Biolagerung und vernetzte Pharma-Lösungen auf der ISPE Singapore 2026](https://longbridge.com/en/news/297810393.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**